Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–12 of 12 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT00381641
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +37 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- Decatur Memorial Hospital Decatur, Illinois, United States
- NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States
- Ingalls Memorial Hospital Harvey, Illinois, United States
NCT01638533
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +125 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
NCT02393690
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +22 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Hoag Memorial Hospital Newport Beach, California, United States
- University of Colorado Hospital Aurora, Colorado, United States
- MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors
NCT01709435
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +30 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Children's Hospital of Orange County Orange, California, United States
- UCSF Medical Center-Parnassus San Francisco, California, United States
- UCSF Medical Center-Mission Bay San Francisco, California, United States
NCT00625846
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +29 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- University of Colorado Hospital Aurora, Colorado, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
NCT01811212
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +28 more
- Locations
-
- MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
NCT00729157
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +16 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00559949
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +15 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
NCT02465060
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Thomas Hospital Fairhope, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
NCT04284774
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +102 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer
NCT04759911
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +25 more
- Locations
-
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- University of Michigan Health Systems Ann Arbor, Michigan, United States
- M D Anderson Cancer Center Houston, Texas, United States
Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer
NCT02152995
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +23 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States